Dr. Deepak Bhatt and Dr. C. Michael Gibson discuss: TRANQUILITY: Efficacy of monthly and quarterly dosing of pacibekitug (IL-6 ligand mAb) targeting inflammation in CKD with high cardiovascular risk August 29, 2026 Disclosures: TBD
Dr. Ashish Sarraju and Dr. C. Michael Gibson discuss: Extremely Long Duration Lp(a) Reduction Following a Single Dose of Kylo-11: Final Data from a First-in-Human Study August 28, 2026 Disclosures: TBD
Dr. Luke Laffin and Dr. C. Michael Gibson discuss: Durability of Effects of CTX310, a CRISPR-Cas9 Gene Editing Targeting ANGPTL3 August 28, 2026 Disclosures: TBD
Dr. Ahmad Masri and Dr. C. Michael Gibson discuss: ACACIA-HCM: Aficamten for symptomatic nonobstructive hypertrophic cardiomyopathy August 28, 2026 Disclosures: TBD
Dr. Boyoung Joung and Dr. C. Michael Gibson discuss: SINGLE-AF: Anticoagulation for atrial fibrillation with intermediate stroke risk August 28, 2026 Disclosures: TBD
Dr. Alexander Hirsch and Dr. C. Michael Gibson discuss: Addition of Computed Tomography-derived Fractional Flow Reserve in the diagnostic pathway of patients with stable coronary artery disease: the FUSION randomized trial August 28, 2026 Sponsored by Heartflow
Dr. Siddharth Patel and Dr. C Michael Gibson Discuss: Long-acting Factor XI Inhibition and Periprocedural Bleeding: A Secondary Analysis from AZALEA-TIMI 71 September 2, 2024 Disclosures: TBD
Dr. Byeong-Keuk Kim and Dr. C Michael Gibson Discuss: OCCUPI – Optical coherence tomography-guided coronary intervention in patients with complex lesions September 2, 2024
Dr. C Michael Gibson and Serge Korijan Discuss: Apolipoprotein A-I infusions and cardiovascular outcomes in patients with acute myocardial infarction and hyperlipidemia, ApoA-I Infusions and Burden of Ischemic Events after Acute Myocardial Infarction September 2, 2024 Disclosures: TBD
